Applied BioCode Corporation (TPE:6598)

Applied BioCode Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	517.62	605.96	413.19	831.32	646.07	847.91
Short-Term Investments	100.55	251.53	191.62	-	-	-
Cash & Short-Term Investments	618.16	857.49	604.82	831.32	646.07	847.91
Cash Growth	-30.83%	41.78%	-27.25%	28.67%	-23.80%	180.14%
Receivables	83.09	45.02	51.04	70.81	67.81	49.47
Inventory	170.03	190.07	174.97	106.68	101.37	106.43
Other Current Assets	6.14	11.71	6.53	5.48	11.2	17.26
Total Current Assets	877.43	1,104	837.36	1,014	826.45	1,021
Property, Plant & Equipment	143.89	98.79	131.14	169.62	162.77	171.52
Other Intangible Assets	0.14	1.8	6.02	10.38	13.43	17.2
Long-Term Deferred Tax Assets	2.89	3.11	4.5	3.99	3.51	4.6
Other Long-Term Assets	6.45	6.92	14.19	14.18	12.8	12.83
Total Assets	1,031	1,215	993.21	1,212	1,019	1,227
Accounts Payable	6.19	6.44	2.58	8.73	9.43	27.6
Accrued Expenses	41.61	35.63	32.08	35.06	26.11	30.3
Current Portion of Leases	19.85	17.26	16.35	15.66	14.2	12.7
Current Income Taxes Payable	3.58	2.53	0.47	1.5	4.18	-
Current Unearned Revenue	35.64	54.59	43.25	22.77	1.99	1.96
Other Current Liabilities	3.43	13.38	6.84	3.91	4.05	5.25
Total Current Liabilities	110.29	129.83	101.56	87.63	59.95	77.8
Long-Term Leases	42.66	2.27	18.08	33.45	44.56	48.73
Long-Term Unearned Revenue	187.39	200.87	208.08	271.33	7.99	9.09
Long-Term Deferred Tax Liabilities	2.89	3.11	4.5	3.99	3.51	4.6
Total Liabilities	343.23	336.07	332.22	396.38	116.01	140.23
Common Stock	1,028	1,028	817.68	817.63	817.29	816.39
Additional Paid-In Capital	36.54	272.28	43.81	359.24	351.58	-
Retained Earnings	-353.54	-453.97	-193.16	-349.93	-165.2	-1,052
Comprehensive Income & Other	-23.55	32.65	-7.34	-10.88	-100.71	1,323
Shareholders' Equity	687.57	878.83	660.99	816.07	902.96	1,087
Total Liabilities & Equity	1,031	1,215	993.21	1,212	1,019	1,227
Total Debt	62.5	19.52	34.43	49.11	58.76	61.43
Net Cash (Debt)	555.66	837.96	570.39	782.21	587.31	786.48
Net Cash Growth	-36.17%	46.91%	-27.08%	33.18%	-25.32%	368.20%
Net Cash Per Share	5.40	9.25	6.98	9.57	7.19	10.14
Filing Date Shares Outstanding	102.81	102.79	81.77	81.76	81.73	81.64
Total Common Shares Outstanding	102.81	102.79	81.77	81.76	81.73	81.64
Working Capital	767.13	974.46	735.8	926.66	766.5	943.28
Book Value Per Share	6.69	8.55	8.08	9.98	11.05	13.31
Tangible Book Value	687.43	877.03	654.97	805.69	889.52	1,070
Tangible Book Value Per Share	6.69	8.53	8.01	9.85	10.88	13.10
Machinery	80.64	78.54	70.92	67.91	91.96	81.71
Construction In Progress	-	-	1.4	17.9	1.01	-
Leasehold Improvements	70.21	75.3	70.79	52.29	46.71	44.37

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.